Results 101 to 110 of about 6,119,378 (259)

Autologous hematopoietic stem cell transplantation for pediatric autoimmune neurologic disorders

open access: yes
Autologous hematopoietic stem cell transplantation (aHSCT) may be effective in carefully selected pediatric patients with multiple sclerosis (MS), neuromyelitis optica (NMO), and chronic inflammatory demyelinating polyneuropathy (CIDP).
Greco, R.   +7 more
core   +1 more source

MSJ802544_supplement_1 – Supplemental material for Autologous hematopoietic stem cell transplantation improves fatigue in multiple sclerosis

open access: yes, 2018
Supplemental material, MSJ802544_supplement_1 for Autologous hematopoietic stem cell transplantation improves fatigue in multiple sclerosis by Gauruv Bose, Harold L Atkins, Marjorie Bowman and Mark S Freedman in Multiple Sclerosis ...
Harold L Atkins (5792789)   +3 more
core   +1 more source

Efficacy of consolidation high-dose chemotherapy with ifosfamide, carboplatin and etoposide (HD-ICE) followed by autologous peripheral blood stem cell rescue in chemosensitive patients with metastatic soft tissue sarcomas [PDF]

open access: yes, 2006
Background: Prognosis of patients with metastatic soft tissue sarcomas (MSTS) is poor even after response to doxorubicin-based chemotherapy. We report phase II data of highdose chemotherapy and peripheral blood stem cell (PBSC) rescue in patients with ...
Hentrich, M.   +33 more
core   +1 more source

Autologous Hematopoietic Stem Cell Transplantation for Refractory Lymphomatoid Granulomatosis

open access: yesHematology, 2002
Lymphomatoid granulomatosis (LG) is a rare lymphoproliferative disorder. There is no standard therapy for refractory patient. Here we present the case of a patient with LG of the lung and the brain who was refractory to polychemotherapy. An autologous hematopoietic stem cell transplantation was done and the patient achieved a complete remission.
Julie, Lemieux   +3 more
openaire   +2 more sources

Hematopoietic stem cell transplantation in rheumatic diseases

open access: yes, 1999
The concept of using hematopoietic stem cell transplantation to treat patients with autoimmune disease was first provided by animal studies and anecdotal case reports. Advances over recent years in autologous hematopoietic stem cell transplantation, most
Brooks, P. M., Snowdon, J. A.
core   +1 more source

The impact of multiple myeloma drugs treatments on autologous stem cell transplantation in the era of new drugs

open access: yesFrontiers in Oncology
Autologous stem cell transplantation (ASCT) is the standard treatment recommended by the National Comprehensive Cancer Network (NCCN) for newly diagnosed multiple myeloma (MM) patients who are eligible for transplantation. This procedure follows response
Xixi Wan   +5 more
doaj   +1 more source

Use of selective serotonin reuptake inhibitors and risk of myeloid malignancy: A nationwide Danish case–control study

open access: yesBritish Journal of Haematology, EarlyView.
Summary Preclinical and clinical studies suggest that selective serotonin reuptake inhibitors (SSRIs) can stimulate haematopoiesis by promoting proliferation and mobilization of haematopoietic stem and progenitor cells, but whether SSRI use influences myeloid malignancy risk remains unclear.
Katrine Mose   +5 more
wiley   +1 more source

Clonal evolution of hematopoietic stem cells after autologous stem cell transplantation

open access: yesNature Genetics
Abstract The impact of exogenous stressors, such as cancer chemotherapies, on the genomic integrity and clonal dynamics of normal hematopoiesis is not well defined. We conducted whole-genome sequencing on 1,276 single-cell-derived hematopoietic stem and progenitor cell (HSPC) colonies from ten patients with multiple myeloma treated ...
Hidetaka Uryu   +43 more
openaire   +2 more sources

Hematopoietic Stem Cell Transplantation in Iran: 1991 through 2010 [PDF]

open access: yesInternational Journal of Hematology-Oncology and Stem Cell Research, 2010
Introduction: This review reports the current results of hematopoietic stem cell transplantation (HSCT) in patients who had received transplantation in the Hematology-Oncology and SCT Research Center, Tehran, Iran.
Ardeshir Ghavamzadeh   +10 more
doaj   +1 more source

Fresh (Non-cryopreserved) autologous stem cell transplantation in multiple myeloma: Faster engraftment and reduced hospitalization

open access: yesHematology, Transfusion and Cell Therapy
Background: Cryopreserved autologous hematopoietic stem cell transplantation using dimethyl sulfoxide is standard in multiple myeloma but it is associated with infusion-related toxicity and high cost. This study aimed to evaluate the feasibility, safety,
Merve Kakci   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy